{"schema_version":"secwatch.filing_event.v1","accession":"0001877322-24-000034","form_type":"8-K","ticker":"ESAB","cik":"0001877322","company_name":"ESAB Corp","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.194755+00:00","generated_at":"2026-06-05T07:25:39.143655+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ESAB Q4 2023 sales $689M, core adj EBITDA $126M (+18%); guides FY2024","bullets":["Q4 sales $689M (+4% core organic growth vs prior year); net income $58M ($0.96 diluted EPS).","Core adjusted net income $69M ($1.13 diluted EPS); core adjusted EBITDA $126M, margin 19.4% (+200 bps).","FY2024 outlook: core organic growth 2.5%-4.5%; core adjusted EBITDA $495M-$515M; core adjusted EPS $4.65-$4.85.","CEO cites strong execution, new products driving growth and EBX initiatives expanding margins."],"urls":{"canonical":"https://secwatch.observer/filing/0001877322-24-000034","json":"https://secwatch.observer/filing/0001877322-24-000034.json","markdown":"https://secwatch.observer/filing/0001877322-24-000034.md","text":"https://secwatch.observer/filing/0001877322-24-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877322/000187732224000034/0001877322-24-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877322/000187732224000034/esab-20240229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:25:39.143655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e1c1d9cae910d9ddf6e448d0d45099dfcbcb56b5","claim":"ESAB Corp reported the fourth quarter ended December 31, 2023 results: revenue $689 million, net income $58 million, EPS $0.96 diluted earnings per share. Guidance initiated.","evidence_excerpt":"“Company”) (NYSE: ESAB), a focused premier industrial compounder, today announced record financial results f or the fourth quarter of 2023. ESAB reported fourth quarter sales of $689 million, an increase of 4% on an as reported basis or 4% higher core organic growth before acquisitions and currency translation impacts, as compared to the prior year. ESAB also","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1877322/000187732224000034/0001877322-24-000034-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$689 million"},{"label":"Net income","value":"$58 million"},{"label":"EPS","value":"$0.96 diluted earnings per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}